Therapeutic Issues for Autism

• Status: Completed
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aimed to show the effects of hyperbaric oxygen therapy and/or Risperidone in improving symptoms of autism

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Minia University
• Treatments: Risperidone

Criteria

Inclusion Criteria:

• age of 5-7 years

• weight of at least 15 kg

Exclusion Criteria:

• Absence of significant medical problems and any other neuropsychiatric disorder requiring drug therapy (e.g., Bipolar disorder, psychosis).

• No concomitant treatment with psychotropic medication was allowed during the study.

• Weight less than 15 kg.

• Other cardiac, liver, gastrointestinal, renal, endocrine, blood and metabolic diseases